about
Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohortHigh levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort.Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis.The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis?Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis.Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis.Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis.Pentosidine, an advanced glycation end-product, may reflect clinical and morphological features of hand osteoarthritisSerum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical RemissionResistin in idiopathic inflammatory myopathies.Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort studyS100A4 (Mts1): is there any relation to the pathogenesis of rheumatoid arthritis?MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritisThe metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts.Prospective new biological therapies for rheumatoid arthritis.Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.The role of resistin as a regulator of inflammation: Implications for various human pathologies.The role of resistin in inflammatory myopathies.Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.An update on biomarkers in axial spondyloarthritis.Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritisThe transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial.Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis.Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA.Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis.The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis.Chronic repetitive nonprogressive epilepsia partialis continua due to rheumatoid meningitis.Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis.Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
P50
Q30839061-9B82D67C-D21A-402F-84E6-85AB37EFA0D3Q30876263-6C5B27B0-D373-4EB4-921F-2FD0106C05EBQ34237586-9BBE2B68-3004-4990-A1F1-20C3A82AB422Q34560305-2C339B89-E312-4D08-BDE5-CDEA7D399019Q34981387-C8C5417D-3E4D-4DEB-BE41-F00938876E32Q35123760-36241658-6F8D-4C3E-B6CE-937D90FAECECQ35617658-953DD96C-E292-4AAA-A801-86CE733D0BE1Q35882730-B666F67E-8C68-4A61-B786-AF39DC8BABE3Q35962863-16C9438E-8F12-4E9C-9905-950BFF3FE04CQ36041246-54A1D230-7187-460E-9A91-FA4ABF62616CQ36067062-F5CB15D3-F9A1-4055-862E-8FAA2F1037A5Q36188496-BE093288-F1A4-4F54-A17B-46FF0FFDFF90Q36245955-D6F9A4D1-88D3-4533-B982-41D85CF41B23Q36321563-B753838E-B9D9-48E1-B9D3-88A7E0BBEDDBQ36375721-531EAE46-6B2A-489F-A8A5-2B1BA9A3F755Q36960767-5AFBC031-931A-4BF1-89D8-9FC8C2E8B683Q37023234-5AA7F330-1BAB-4E59-89AE-9B03E0C75804Q37425627-B58BD381-CD3B-4292-9831-3BD69196FC62Q37442813-37ADE0C2-6CAC-42FC-8F63-37610F60DDCCQ37594310-54A32E33-4DC7-49CC-9BDA-4C33B67C402BQ38099557-73C338F3-AFCE-4AB6-8DF7-6C1855EFEC7CQ38702140-8FA73E20-A914-45FC-B17B-D7A13BA8CEFCQ38724854-F091158F-AA9E-4FE2-A15E-DEEA1308BBFDQ38818188-CE72B524-BA54-4AE5-A258-311D4D0064E9Q39236631-A6F1DC18-2A51-492A-A9FC-663D10F25E67Q41468717-9DAE39C0-FB2F-43B6-A71C-508984CB60A9Q41497288-610641C9-D96A-42CD-9DE1-BEAA2FEA8171Q42955189-554C5B24-E8AF-42C4-A9F1-1784CCE952FAQ43204037-85425E76-30DE-498E-A1C9-02A9BC7411C2Q44297693-A606D7B3-D858-4037-B161-E56BEC304A53Q44800988-34FF72B9-FA52-43C7-AA20-841B910E26C6Q44832774-BAF070A6-72EA-46EB-919A-5F87EDEC393EQ44918219-4950F0DF-46FD-4B88-BD0E-71514C5E6E71Q45675445-15AC6F3C-221B-4AE2-BBF0-0C79B9ACF33BQ45971063-6FAFF5B9-CECC-4139-B8B6-1AB58904D611Q51663216-412A0B3C-CC81-43AE-8185-9ADB52EB2F2CQ51730918-B7A7CFAB-CF1C-48F2-A173-B2D07F89ABD9Q54176920-1CD775AB-B640-4D42-AE53-0548BAF66A38Q54940316-6DA0CF1F-9624-4039-A5D5-22133557A1C0Q57752293-C37C98C4-E6F0-419A-AA81-F9563C583B01
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ladislav Senolt
@ast
Ladislav Senolt
@en
Ladislav Senolt
@es
Ladislav Senolt
@nl
Ladislav Senolt
@sl
type
label
Ladislav Senolt
@ast
Ladislav Senolt
@en
Ladislav Senolt
@es
Ladislav Senolt
@nl
Ladislav Senolt
@sl
altLabel
Ladislav Šenolt
@en
prefLabel
Ladislav Senolt
@ast
Ladislav Senolt
@en
Ladislav Senolt
@es
Ladislav Senolt
@nl
Ladislav Senolt
@sl
P1053
O-6097-2017
P106
P1153
11840159600
P21
P31
P3829
P496
0000-0001-5500-7312